Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
US7550470B2 · kind B2 · utility
92Cited by
11References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 5, 2003 |
| Grant date | Jun 23, 2009 |
| Priority date | — |
| Expiry date | Nov 30, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, macular edema, retinal ischemia, inflammatory diseases, and the like in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.